AbbVie says it reconsiders merger pact with Shire

Pharmaceutical giant AbbVie Inc. signals it is having second thoughts about its planned acquisition of Shire PLC, saying its board will reconsider the $54 billion deal in light of new Treasury rules that make it less attractive.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.